FCGR2B, also known as Fc Gamma Receptor IIb or CD32b, situated at 1q23.3, is increasingly recognized as a pivotal factor influencing the progression and treatment responses in leukemia and lymphoma cases43,44. This evidence concerns the gene FCGR2B and leukemia.